Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q1 2026: Amgen 8.618, Roche 17.1305.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Amgen vs Roche Net Worth and Market Cap
Amgen (AMGN) and Roche (RHHBY) are peers in GLP-1. Amgen reported revenue of $8.6B as of Q1 2026, compared with $34.3B for Roche. Roche leads on revenue.
Amgen's gross margin is 68.2% versus 71.7% for Roche. Amgen's net margin is 21.1% versus 17.9% for Roche.
Key differences
- Revenue growth on the same quarter a year earlier: Amgen +5.8% (Q1 2026), Roche -4.2% (Q4 2025).
- Amgen keeps more of its revenue as operating profit: a 30.9% operating margin, against 23.2% at Roche.
- Amgen's KPIs on Sterling include AMG 513 Obesity Discontinuation and Cash and Cash Equivalents.
- Roche's KPIs on Sterling include Carmot Asset Pipeline: CT-388, CT-996, CT-868 Trial Readout Timeline and CT-868 (Acmopatide) Discontinuation.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, Roche.| Metric | Amgen | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $8.62B | $34.26B |
| Cost of Revenue | $2.74B | $9.68B |
| Gross Profit | $5.87B | $24.58B |
| Operating Income | $2.67B | $7.96B |
| Net Income | $1.82B | $6.13B |
| R&D Expense | $1.72B | $7.48B |
| Earnings Per Share | $3.34 | $0.95 |
| Gross Margin | 68.2% | 71.7% |
| Operating Margin | 30.9% | 23.2% |
| Net Profit Margin | 21.1% | 17.9% |
| Free Cash Flow | $1.48B | $10.67B |
| Cumulative Free Cash Flow | $165.69B | $299.34B |
| Operating Cash Flow | $2.19B | $13.12B |
| Cash & Equivalents | $12.04B | $6.32B |